Text and Data Mining valid from 2018-06-19
Received: 9 November 2017
Accepted: 1 May 2018
First Online: 19 June 2018
: The authors declare no competing interests and note that previous patents held by A.O.G. on the use of the blood transcriptomic for diagnosis of tuberculosis have lapsed and discontinued. Neither bioMérieux nor BIOASTER have filed patents related to this study.